Author

Pashupati Bhandari

University of SaskatchewanORCID 0000-0002-2616-9934Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander PeidliD· 1 shared Andrew LeaskiD· 1 shared Bahja Ahmed AbdiiD· 1 shared Bruce L. Riser· 1 shared Connor DenomyiD· 1 shared David E. Carter· 1 shared Dinesh KhannaiD· 1 shared James Varani· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Alexander PeidlORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CCN3-derived peptide BLR-200 impairs YAP activation and attenuates bleomycin-induced skin fibrosis through blocking the generation of Sfrp2-positive fibroblasts

John Nguyen, Alexander Peidl, Pratyusha Chitturi, Shannon D. McClintock, Randall Knibbs, Zestranjyan Kannan, Bahja Ahmed Abdi, Connor Denomy, Pashupati Bhandari, David E. Carter, Mathieu Petitjean, John Varga, Dinesh Khanna, Richard J. Stratton, Mohammed Nadeem Aslam, , Andrew Leask

This paper identifies BLR-200, a CCN3-derived peptide, as an anti-fibrotic agent that impairs YAP activation and reduces bleomycin-induced skin fibrosis by blocking Sfrp2-positive fibroblast generation.

bioRxiv · Jul 8, 2026 · PreprintCell Biology